ResMed (RMD) Tops Q4 EPS by 25c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
ResMed (RMD) PT Raised to $212 at Oppenheimer
August 6, 2020 8:14 AM EDTOppenheimer analyst Suraj Kalia raised the price target on ResMed (NYSE: RMD) to $212.00 (from $200.00) while maintaining an Outperform rating.
The analyst commented, "ResMed reported 4Q20 revenue slightly higher than consensus estimate at $752M, and roughly in line with our $770M estimate. Pull-through... More
